PCA
GILD icon

Providence Capital Advisors’s Gilead Sciences GILD Stock Holding History

Providence Capital Advisors’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-430
Closed -$36.1K – 195
2024
Q3 		$36.1K Buy
430
+1
+0.2% +$76 0.01% 188
2024
Q2 		$29.5K Buy
429
+1
+0.2% +$67 0.01% 186
2024
Q1 		$31.4K Buy
428
+1
+0.2% +$77 0.01% 182
2023
Q4 		$34.6K Buy
427
+1
+0.2% +$78 0.01% 184
2023
Q3 		$31.9K Buy
426
+2
+0.5% +$154 0.01% 179
2023
Q2 		$32.8K Buy
424
+215
+103% +$17.1K 0.01% 169
2023
Q1 		$17.4K Hold
209
– – ﹤0.01% 190
2022
Q4 		$17.9K Buy
209
+1
+0.5% +$79 ﹤0.01% 178
2022
Q3 		$13K Sell
208
-9
-4% -$568 ﹤0.01% 204
2022
Q2 		$13K Buy
217
+102
+89% +$6.32K ﹤0.01% 197
2022
Q1 		$7K Buy
115
+1
+0.9% +$64 ﹤0.01% 254
2021
Q4 		$8K Sell
114
-1
-0.9% -$69 ﹤0.01% 237
2021
Q3 		$8K Sell
115
-63,199
-100% -$4.44M ﹤0.01% 231
2021
Q2 		$4.36M Buy
63,314
+2,591
+4% +$173K 1.41% 25
2021
Q1 		$3.92M Buy
60,723
+2,121
+4% +$137K 1.43% 28
2020
Q4 		$3.41M Buy
58,602
+11,700
+25% +$706K 1.4% 35
2020
Q3 		$2.96M Buy
46,902
+9,700
+26% +$673K 1.56% 26
2020
Q2 		$2.86M Sell
37,202
-9,398
-20% -$720K 1.62% 25
2020
Q1 		$3.48M Buy
46,600
+1,900
+4% +$131K 2.1% 10
2019
Q4 		$2.9M Buy
+44,700
New +$2.91M 1.56% 22
2019
Q3 		– Sell
-6
Closed – – 235
2019
Q2 		$0 Buy
+6
New +$395 ﹤0.01% 266
2018
Q4 		– Sell
-40
Closed -$3K – 257
2018
Q3 		$3K Hold
40
– – ﹤0.01% 243
2018
Q2 		$3K Sell
40
-73
-65% -$5.16K ﹤0.01% 239
2018
Q1 		$9K Hold
113
– – 0.01% 184
2017
Q4 		$8K Buy
+113
New +$8.58K 0.01% 216

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Providence Capital Advisors's GILD Position: Q4 2024 in Review

Providence Capital Advisors sold out of Gilead Sciences (GILD) in Q4 2024, closing a stake of 430 shares — an estimated $36.1K sold.

Providence Capital Advisors first reported a position in GILD in Q4 2017 and held it in 25 quarters. The position peaked at $4.36M in Q2 2021. 1,887 funds tracked by Wall St. Rank hold GILD as of Q4 2024.

  • Providence Capital Advisors reported no remaining Gilead Sciences position as of Q4 2024 after selling out during the quarter.
  • Providence Capital Advisors sold 430 Gilead Sciences shares in Q4 2024, an estimated $36.1K.
  • Providence Capital Advisors first reported a position in Gilead Sciences in Q4 2017 and held it in 25 quarters.
  • Providence Capital Advisors's Gilead Sciences position peaked at $4.36M in Q2 2021.
  • 1,887 funds tracked by Wall St. Rank held Gilead Sciences as of Q4 2024.

Based on Providence Capital Advisors's 13F filing for Q4 2024, filed 12 Feb 2025.